Highlights Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-05-02 pm EDT			Pre-market 09:21:15 am
149.9 ^USD	-0.83%		150.2	+0.18%

May. 02	Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple...
May. 02	J&J: applies to the EMA for an extended MA for Tremfya	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple...	May. 02
Sector Update: Health Care Stocks Rise Late Afternoon	May. 01	MT
Stocks rise after Fed rate decision, Powell press conference	May. 01	RE
Sector Update: Health Care Stocks Advance Wednesday Afternoon	May. 01	MT
Top Midday Stories: CVS Reports Q1 Earnings Miss, Lowers Outlook; ADP Q1 Earnings Top Estimates; J&J Proposes $6.5 Billion Settlement for Talc Lawsuits	May. 01	MT
Johnson & Johnson Seeks EU Approval for Ulcerative Colitis, Crohn’s Disease Drug	May. 01	MT
Nasdaq, S&P 500 fall as investors take cover before Fed decision	May. 01	RE
Johnson & Johnson Announces $6.48 Billion Plan for Unit to Resolve Ovarian Cancer Talc Claims	May. 01	MT
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday	May. 01	MT
Sector Update: Health Care	May. 01	MT
Johnson & Johnson Announces Plan For Subsidiary to Resolve Ovarian Cancer Talc Claims	May. 01	MT
J&J advances $6.475 billion settlement of talc cancer lawsuits	May. 01	RE
Johnson & Johnson to Consolidate Business Segments Under UK Brand	May. 01	MT
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants	Apr. 30	RE
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	Apr. 30
J&J, Bristol Myers lose challenges to US drug price negotiation program	Apr. 29	RE
J&J: positive CHMP opinion for lung cancer	Apr. 29	CF
Addex Therapeutics Shares Plunge Premarket on Epilepsy Study Failure	Apr. 29	DJ
Johnson & Johnson Says Europe's CHMP Recommends Approval of Rybrevant Plus Chemotherapy for Lung Cancer Treatment	Apr. 26	MT
Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset	Apr. 24	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST